trending Market Intelligence /marketintelligence/en/news-insights/trending/kgiuomra0uo51cxmfekd6q2 content esgSubNav
In This List

SIGA Technologies to relist on Nasdaq

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


SIGA Technologies to relist on Nasdaq

New York-based SIGA Technologies, Inc. said it will relist on the Nasdaq Global Market on March 22.

The company's stock will trade under the SIGA ticker symbol.

SIGA Technologies is the developer of oral Tpoxx, also known as tecovirimat, to treat smallpox. The treatment is being reviewed by the U.S. Food and Drug Administration for approval.